Searched for
ONCOLOGY INJECTABLE MANUFACTURING
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analysts
- Government may lift price cap on cancer drugs making them costlier by up to 50%
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...03 Jun, 2026, 02.36 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...01 Jun, 2026, 01.29 PM IST
- Cenexi recovery, new product launches and capacity additions power Gland Pharma outlookGland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving p...21 May, 2026, 06.20 AM IST
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...20 May, 2026, 12.18 PM IST
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...18 May, 2026, 10.31 PM IST
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...10 May, 2026, 08.50 AM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...06 May, 2026, 11.19 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Sun Pharma: How a small Kolkata trader became a global buyout artistSun Pharma, led by Dilip Shanghvi, is poised for its largest overseas acquisition, a $12.5 billion deal for Organon & Co. This move continu...27 Apr, 2026, 02.24 PM IST
- Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 croreQuadria Capital is eyeing a strategic acquisition of a majority interest in Samarth Lifesciences, a move that could value the transaction a...23 Apr, 2026, 06.00 AM IST
- Zydus Lifesciences gets USFDA nod for Leuprolide Acetate injectionZydus Lifesciences has secured final approval from the US health regulator for its generic Leuprolide Acetate injection. This medication is...14 Nov, 2025, 02.38 PM IST
- BDR Pharmaceuticals plans $100 mn expansion in the US with manufacturing buyoutsBDR Pharmaceuticals is set to broaden its presence in the US through acquisitions of manufacturing facilities, backed by a $100 million inv...30 Apr, 2025, 05.23 PM IST
- Aurobindo Pharma to hive off injectables businessIndian drugmaker Aurobindo Pharma has decided to hive off its injectables business into a wholly owned subsidiary.10 Aug, 2013, 04.40 PM IST
- Strides Arcolab gets approval for facility, anti-bacterial injectionDrug firm Strides Arcolab today said it has received approval from the European authorities for its Bangalore-based oncology facility.01 Jul, 2011, 01.42 PM IST
- Venus: Phase IV of Baddi projectVenus Remedies has completed Phase IV of the Baddi project comprising two dedicated plants for specialty formulations.07 Aug, 2007, 11.06 AM IST
- Zenotech to market Ranbaxy’s oncology products in N AmericaRanbaxy on Wednesday announced a strategic tie-up with Hyderabad-based Zenotech Laboratories for marketing the latter’s oncology products i...08 Jun, 2006, 12.37 AM IST
Load More
